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Available online xxxxIdentiﬁcation of reliable biomarkers of prognosis in subjects with high risk to psychosis is an essential step to im-
prove care and treatment of this population of help-seekers. Longitudinal studies highlight some clinical criteria,
cognitive deﬁcits, patterns of graymatter alterations and proﬁles of bloodmetabolites that provide some levels of
prediction regarding the conversion to psychosis. Further effort is warranted to validate these results and imple-
ment these types of approaches in clinical settings. Such biomarkersmay however fall short in entangling the bi-
ologicalmechanisms underlying the disease progression, an essential step in the development of novel therapies.
Circuit-based approaches, which map onwell-identiﬁed cerebral functions, could meet these needs. Converging
evidence indicates that thalamus abnormalities are central to schizophrenia pathophysiology, contributing to
clinical symptoms, cognitive and sensory deﬁcits. This review highlights the various thalamus-related anomalies
reported in individuals with genetic risks and in the different phases of the disorder, from prodromal to chronic
stages. Several anomalies are potent endophenotypes, while others exist in clinical high-risk subjects andworsen
in thosewho convert to full psychosis. Aberrant functional coupling between thalamus and cortex, low glutamate
content and readouts from resting EEG carry predictive values for transition to psychosis or functional outcome.
In this context, thalamus-related anomalies represent a valuable entry point to tackle circuit-based alterations as-
sociated with the emergence of psychosis. This review also proposes that longitudinal surveys of neuroimaging,
EEG readouts associatedwith circuits encompassing themediodorsal, pulvinar in high-risk individuals could un-
veil biological mechanisms contributing to this psychiatric disorder.
© 2019 The Author. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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The onset of diagnosed psychosis is preceded by a prodromal phase
that is characterized by the presence of basic symptoms and sub-
threshold positive symptoms. A set of criteria is used to identify individ-
uals with potential prodromal symptoms. This includes 1) a genetic risk
and a decline in functioning, 2) attenuated psychotic symptoms, and
3) brief limited intermittent psychotic episode (Fusar-Poli et al.,
2013). Individuals with at least one of these criteria are considered as
clinical high risk for psychosis. However, such a deﬁned clinical high-
risk group is not homogeneous. Many clinical high-risk subjects may
never convert to full psychosis, but show other psychiatric outcome
and retain relatively low levels of functioning. Ameta-analysis indicates
a mean of transition risk of about 20% after one-year follow-up (Fusar-
Poli et al., 2012). Treatment and patient care during this prodromal
phase may also reduce the risk to convert to full psychosis. Therefore,
it is essential to develop diagnostic tools to improve the prediction of
conversion to psychosis and other outcomes among this population.linical high-risk subjects.
. This is an open access article under
us-related anomalies as cand
.05.027This includes the identiﬁcation of reliable biomarkers of risk and prog-
nosis. In this context, the “Attenuated Psychosis Syndrome” is proposed
as a new diagnostic category that would better describe the prodromal
phase and capture sub-threshold psychotic symptoms before they de-
velop into a full psychotic disorder like schizophrenia. Many efforts
have been engaged in identifyingparameters that could discriminate in-
dividualswho convert to psychosis from thosewhodonot. Thus, clinical
variables (Ruhrmann et al., 2010), mild cognitive deﬁcits (Seidman
et al., 2016), reduced gray matter in prefrontal, cingulate, striatal, and
cerebella regions (Koutsouleris et al., 2015), peripheral blood markers
(Chan et al., 2015) carry predictive values. Advanced neuroimaging
and machine-learning based analytical methods will further help reﬁn-
ing the prediction of conversion risk and functional outcome (de Wit
et al., 2017; Kambeitz-Ilankovic et al., 2018). These approaches may
provide invaluable tools to clinicians. However, they may fall short in
probing the biological mechanisms underlying the progression of the
disorder, a necessary step for the development of novel therapies. In
this context, a biology-driven approach based on deﬁned brain circuits
affected in the disorder and associated with well-identiﬁed functions,
could meet these needs. Thalamus-related anomalies represent a valu-
able entry point to tackle circuit-based alterations associated with thethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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of evidence has revealed the involvement of the thalamus in the patho-
physiology of schizophrenia (Andreasen, 1997; Byne et al., 2009;
Clinton and Meador-Woodruff, 2004; McCarley et al., 1999). As part of
multiple brain networks, the thalamus represents an essential hub for
cognitive processes and an interface between sensory and motor sys-
tems. Therefore, thalamus dysfunction may potentially contribute to
symptoms and deﬁcits found in schizophrenia. This includes working
memory and attention deﬁcits, impairment of ﬂexible-goal directed
tasks, altered sensory perception, inability to properly recognize self-
initiated motor outputs, sleep disruption (Behrendt, 2006; Cronenwett
and Csernansky, 2010). The thalamus is mostly composed of excitatory
neurons grouped into separate nuclei that have distinct patterns of con-
nections with the cortex, subcortical brain structures, and sensory sys-
tems. This deﬁnes the function of each nucleus. Some nuclei relay
sensory stimuli to primary sensory cortices. The lateral geniculate, me-
dial geniculate, and ventral posterior nuclei constitute respectively the
visual, auditory, and somatosensory thalamic nuclei. Other nuclei con-
vey to the cortex more processed information coming from the cortex
and/or a variety of subcortical structures. These nuclei can be classiﬁed
as motor relays (ventral lateral, ventral anterior nuclei), associative
(e.g. anterior andmediodorsal nucleus, pulvinar), or non-speciﬁc (mid-
line, intralaminar nuclei). In addition, the thalamus is surrounded later-
ally by the thalamic reticular nucleus (TRN). This nucleus is composed of
a dense layer of GABAergic neurons projecting into the different tha-
lamic nuclei to inhibit thalamocortical neurons. Consequently, the TRN
occupies a key position as gate-keeper to orchestrate thalamo-cortical
and thalamo-striatal information ﬂow. A comprehensive description of
the thalamus anatomy and function is beyond the scope of this review
(see Jones, 2007; Sherman and Guillery, 2013). However, Table 1 pro-
vides a brief description of the connections and functions of some nuclei
discussed in the present review.Table 1
Thalamic nuclei relevant to schizophrenia with their main connections and currently known fu
Nucleus Connectivity Roles
Anterior complex
(anterodorsal,
anteromedial,
anteroventral)
- Direct and indirect interconnections with hippocam-
pus
- Reciprocal connections with prefrontal, anterior cin-
gulate and retrosplenial cortices
- Inv
iga
- Inv
du
Midline nuclei (i.e.
reuniens)
- Interconnected with hippocampus and limbic cortical
regions
- Major source of thalamic inputs to the hippocampus
- Inv
be
- Mo
th
ne
Intralaminar nuclei
(i.e. centromedian
nucleus)
- Receive inputs from brainstem and subcortical
regions, cerebellum
- Project to dorsal striatum, amygdala and a wide range
of cortical regions
- Pr
go
- Inv
sle
Mediodorsal nucleus - Reciprocal connections with prefrontal regions
- Receives inputs from amygdala, limbic system, basal
ganglia, midbrain and brainstem
- Receives collateral inputs from cortical neurons
projecting to subcortical motor regions
- Inv
wo
ﬂe
- Re
tio
reg
Pulvinar - Receives inputs from superior colliculus
- Reciprocally connected with prefrontal, temporal,
parietal and occipital cortices
- En
- Re
co
- Pa
or
att
os
Thalamic reticular
nucleus (TRN)
- Constituted of inhibitory neurons that project into the
thalamic nuclei
- Receives strong collateral excitatory inputs from tha-
lamic neurons projecting to the cortex and cortical
layer VI pyramidal neurons projecting into the tha-
lamic nuclei
- Receives projections of a wide range of sources (basal
ganglia, hypothalamus, amygdala, forebrain)
- Mo
inf
ac
- Im
- Pr
ce
sle
- Inv
NR
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search, https://doi.org/10.1016/j.schres.2019.05.027Most postmortem studies of schizophrenia patients have examined
nuclei that do not process primary sensory stimuli (reviews: Byne
et al., 2009; Dorph-Petersen and Lewis, 2017). Smaller volume and/or
reduced number of neurons are robust ﬁndings for the pulvinar (Byne
et al., 2002; Danos et al., 2003; Highley et al., 2003; Mileaf and Byne,
2012). Similar anomalies (including decreased number of glial cells)
are reported in mediodorsal and anterior nuclei althoughwith less con-
sistency (Byne et al., 2002; Byne et al., 2006; Chana et al., 2008; Cullen
et al., 2003; Dixon and Harper, 2004; Kreczmanski et al., 2007;
Pakkenberg, 1990; Popken et al., 2000; Young et al., 2000). A trend to-
wards reduced volume of the centromedian nucleus (part of the
intralaminar nuclei) has been also reported (Byne et al., 2002), whereas
no alterations in the lateral geniculate (Dorph-Petersen et al., 2009;
Selemon and Begovic, 2007) and ventral posterior (Popken et al.,
2000) nuclei have been found. Finally, the TRN of patients displays a re-
duced number and density of parvalbumin-immunoreactive neurons
and altered extracellular matrix (Steullet et al., 2018). Altogether, post-
mortem studies pinpoint abnormalities mostly in several high-order
nuclei and TRN. However, these do not clarifywhether these are disease
speciﬁc or caused by the interactions between illness, medication, and
age. Furthermore, they do not inform about the temporal changes that
occur along the different stages of the disorder. Understanding the on-
togeny and nature of anomalies at the levels of individual thalamic nu-
clei and their associated circuits may lead to the identiﬁcation of
biologically relevant biomarkers. Recent preclinical studies have shed
new light on the circuits-based mechanisms that support working
memory, attention and memory consolidation. These involve thalamic
nuclei known to be affected in schizophrenia (i.e. mediodorsal nucleus,
pulvinar and TRN) (i.e. Barron et al., 2015; Bolkan et al., 2017; Fogel and
Smith, 2011; Schmitt et al., 2017; Wimmer et al., 2015; Yu et al., 2018).
In this context, impairments in attention, workingmemory, and declar-
ative memory can be present during the premorbid phase, tend tonctions.
References
olved in mnesic functions and spatial nav-
tion
olved in propagation of EEG slow-waves
ring NREM sleep
(Gent et al., 2018; Jankowski et al.,
2013)
olved in tasks requiring interactions
tween hippocampus and prefrontal cortex
dulate in concert with the hippocampus
e activity of midbrain dopaminergic
urons
(Perez and Lodge, 2018; Saalmann,
2014; Vertes et al., 2015; Zimmerman
and Grace, 2016)
obably involved in attention, arousal, and
al-oriented response to relevant stimuli
olved in EEG slow-waves during NREM
ep
(Gent et al., 2018; Saalmann, 2014;
Vertes et al., 2015)
olved in goal-directed tasks relying on
rking memory, attention and behavioral
xibility
lays information regarding motor instruc-
ns as efferent copies to other cortical
ions
(Ouhaz et al., 2018; Parnaudeau et al.,
2018; Schmitt et al., 2017; Sherman,
2016)
gaged in several domains of attention
gulates synchronization between multiple
rtical regions during attentional task
rticipates in the suppression of distractors
stimuli to be ignored during selective
ention via the modulation of cortical alpha
cillations
(Barron et al., 2015; Grieve et al., 2000;
Ketz et al., 2015; Pessoa and Adolphs,
2010; Saalmann et al., 2012; Zhou
et al., 2016)
dulates and gates thalamo-cortical ﬂow of
ormation, inﬂuencing the states of cortical
tivity
plicated in arousal, attention and sleep
obably implicated in consolidation of pro-
dural and declarative memories during
ep
olved in generation of EEG spindles during
EM sleep
(Chen et al., 2015; Clemente-Perez
et al., 2017; Crabtree, 2018; Herrera
et al., 2016; Pinault, 2004)
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3P. Steullet / Schizophrenia Research xxx (xxxx) xxxworsen during the prodromal stage, and are quite consistently
associated with later conversion to psychosis (Dickson et al., 2012;
Keshavan et al., 2010; Seidman et al., 2016). Progressive alterations
within some thalamic could therefore contribute to the decline of cogni-
tive capacities. Moreover, preclinical data support the hypothesis that
thalamic dysfunction contribute to the dysregulation of the dopaminergic
system leading to the emergence of positive symptoms (Lisman et al.,
2010). Indeed, midline thalamic nuclei (reuniens and paraventricular nu-
clei) regulate, in concert with the hippocampus, the activity of dopami-
nergic neurons (Perez and Lodge, 2018; Zimmerman and Grace, 2016).
A large body of evidence from structural and functional magnetic
resonance imaging (MRI), magnetic resonance spectroscopy (MRS),
and electroencephalography (EEG) indicates signiﬁcant thalamic ab-
normalities in schizophrenia, from the early-course of the disorder to
the chronic stages. The goal of the present article is to ﬁrst provide,
based on MRI (structural, functional, MRS) and EEG studies, an integra-
tive overview on the thalamus-related abnormalities found respectively
in patients suffering from chronic schizophrenia,ﬁrst psychotic episode,
and individuals at clinical and genetic high-risk. Based on the existing
literature, the second part of the article will highlight potent
endophenotypes and candidate predictive biomarkers for psychosis,
and their potential clinical and translational relevance.
2. Thalamus-related abnormalities in chronic schizophrenia and
ﬁrst episode psychosis patients
2.1. MRI studies
Due to a lack of sufﬁcient resolution and contrast, imaging the thal-
amus is a challenging task, particularly when aiming to investigate sep-
arately each of the functionally distinct nuclei. Therefore, a large
majority of studies have investigated the thalamus as awhole. However,
newly-developed analytical methods allow now to segment the thala-
mus into several subregions (Akram et al., 2018; Iglesias et al., 2018;
Najdenovska et al., 2018). Thus, large nuclei, such as the pulvinar and
mediodorsal nucleus, can be more reliably studied. But many other
nuclei (i.e. the midline and intralaminar nuclei, TRN) remain currently
inaccessible for proper analysis.
2.1.1. Thalamic structural alterations
Avariety ofMRImeasurements has been used to assess structural in-
tegrity of the thalamus. This includes volume and shape of the thalamus,
gray matter (GM) quantiﬁcation, and water diffusion properties as re-
vealed by diffusion-weighted MRI. Results from these investigations
mostly corroborate postmortem data. Meta-analyses and consortium
studies incorporating large cohorts reveal smaller volume of the thala-
mus in chronic (Adriano et al., 2010; Konick and Friedman, 2001;
Okada et al., 2016; van Erp et al., 2016) and newly diagnosed patients
(Adriano et al., 2010; Qiu et al., 2009), as compared to control subjects.
Noteworthy, anothermeta-analysis indicates the presence of more pro-
nounced effects in antipsychotic-naïve than in medicated patients
(Haijma et al., 2013). This suggests that structural thalamic anomalies
are present early-on during the course of the disease and are attenuated
by antipsychotic treatments. Regarding the quantiﬁcation of thalamic
GM volume, a reduction in schizophrenia patients is supported by a
meta-analysis (Glahn et al., 2008) and a recent study on two large co-
horts (Maggioni et al., 2017). However, in ﬁrst-episode psychosis, GM
loss is less clear. Some studies found no signiﬁcant GM volume alter-
ations (Chan et al., 2011), while others reported reduced thalamic GM
volume (Huang et al., 2015). The later report showed that GM was
more affected in ﬁrst-episode patients presenting auditory hallucina-
tion symptoms. In a large-scale longitudinal prospective study in
which early psychotic patients were followed over many years, the
rate of decrease of GM volume in the thalamus was most severe during
the ﬁrst years of the disorder (Andreasen et al., 2011). Mounting evi-
dence also points to uneven structural alterations across nuclei.Please cite this article as: P. Steullet, Thalamus-related anomalies as cand
search, https://doi.org/10.1016/j.schres.2019.05.027Thalamic surface shape deformation in chronic and ﬁrst-episode pa-
tients suggests structural alterations in anterior, posterior, mediodorsal
and ventrolateral regions of the thalamus (Coscia et al., 2009; Danivas
et al., 2013; Harms et al., 2007; Qiu et al., 2009; Skatun et al., 2018;
Smith et al., 2011). In a cohort of early-onset psychosis, the volume
reduction of the thalamus was primary due to decreased volume in
the anterior mediodorsal area and pulvinar (Janssen et al., 2012).
Voxel-basedmorphometry (VBM) studies further support a focal reduc-
tion of GM, with GM loss most often centered on the mediodorsal and
midline nuclei (Pergola et al., 2015). In chronic patients, microstructural
alterations of the thalamus have also been observed by diffusion-
weighted MRI (Agarwal et al., 2008; Li et al., 2016; Rose et al., 2006).
Increased water diffusivity was particularly evident in the anterior
and mediodorsal parts (Rose et al., 2006). Likewise, ﬁrst-episode
patients display diffusion-sensitive microstructural alterations in the
mediodorsal and pulvinar regions connected to orbitofrontal and
latero-temporal cortices (Cho et al., 2019b).
2.1.2. Neurochemical proﬁle alterations
Meta-analyses of MRS studies revealed a decrease of N-
acetylaspartate (NAA) in the thalamus of schizophrenia (Kraguljac
et al., 2012) and ﬁrst-episode patients (Brugger et al., 2011; Wang
et al., 2019). A recent study also reports a decrease in glutathione con-
tent in ﬁrst-episode patients (Wang et al., 2019). By contrast, current
data do not show very consistent alterations of glutamate and gluta-
mine levels in ﬁrst-episode and chronic patients (Merritt et al., 2016;
Wang et al., 2019). However, this could be linked to the sparsity of
studies.
2.1.3. Abnormal connectivity
By applying probabilistic tractography with either the thalamus or
cortex as seed region, several groups have highlighted in chronic pa-
tients reduced structural connectivity between the thalamus and corti-
cal prefrontal areas, but increased connectivity with somatomotor,
somatosensory and occipital cortices (Giraldo-Chica et al., 2018;
Marenco et al., 2012). Similar abnormal connectivity between thalamus
and cortex is reported in ﬁrst-episode psychosis (Cho et al., 2016). By
correlating the static bold signals (averaged over several minutes)
across brain regions during resting state fMRI, studies reveal also consis-
tent disturbances in functional coupling between the thalamus and sev-
eral brain regions (prefrontal and sensory-motor cortices, cerebellum,
striatum and hippocampus). In chronic patients, they show a reduction
in functional connectivity of the thalamus with prefrontal and cingulate
cortices (Anticevic et al., 2014; Avram et al., 2018; Giraldo-Chica and
Woodward, 2017; Penner et al., 2018; Skatun et al., 2018; Tu et al.,
2013;Welsh et al., 2010;Woodward et al., 2012). By contrast, there is in-
creased functional coupling between thalamus and sensorimotor cortices
(Anticevic et al., 2014; Giraldo-Chica and Woodward, 2017; Klingner
et al., 2014; Skatun et al., 2018; Skudlarski et al., 2010),which is correlated
with the symptoms (Anticevic et al., 2014). Interestingly, glucose metab-
olism is reduced in themediodorsal nucleus, but increased in the pulvinar
(Hazlett et al., 2004). In addition, reduced and increased functional cou-
pling with respectively the cerebellum and parahippocampus are re-
ported in schizophrenia patients (Anticevic et al., 2014; Tu et al., 2013).
A recent study demonstrated that thalamo-cortical hypo and hyper func-
tional coupling extend to the basal ganglia (Avram et al., 2018). This indi-
cates that disrupted cortico-thalamic networks are embedded into
abnormal cortico-striato-thalamic loops. Similar aberrant functional cou-
plingwithin thalamo-cortical circuits and reduced functional connectivity
between thalamus and striatum are present in the early stages of psycho-
sis (Martino et al., 2018; Woodward and Heckers, 2016).
Altogether, MRI data reveal structural anomalies in the thalamus of
ﬁrst-episode and chronic patients. These anomalies are found preferen-
tially in anterior, mediodorsal and posterior parts. Moreover, aberrant
functional connectivity between thalamus and other brain structuresidate mechanism-based biomarkers for psychosis, Schizophrenia Re-
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of schizophrenia.
2.2. EEG studies
As gateway to the cortex, the thalamus inﬂuences cortical neuronal
activation and synchrony that can be captured by EEG. For instance,
the pulvinar modulates cortical alpha oscillations (Liu et al., 2012;
Lopes da Silva et al., 1980); delta oscillations are the consequence of
low frequency recurrent activation within thalamo-cortical loops
(Steriade, 2003); sleep spindles during NREM sleep rely on TRN neuron
activity (Steriade, 2003). During NREM sleep, slow-waves are initiated
in frontal areas and propagate to posterior cortical regions through
trans-thalamic pathways (Gent et al., 2018). EEG-coupled fMRI
methods reveal that the activity of thalamic nuclei during resting dis-
plays distinct patterns of correlations with individual EEG microstates
associated with speciﬁc EEG oscillations (Schwab et al., 2015). Thus,
the activity of the anterior nuclei is associated with cortical beta oscilla-
tions, while the activity of the medial nuclei is linked to both alpha and
beta oscillations. Thus, some EEG features can provide indirect but rele-
vant information on how different thalamic nuclei communicate with
the cortex. Below, is a brief review of the main ﬁndings on EEG alter-
ations reported in schizophrenia during resting and sleep.
The dynamic succession of EEG microstates during the resting state
is altered in patients, with the microstate associated with the fronto-
parietal attention network being decreased while that related to the sa-
liency network being increased (Rieger et al., 2016). A meta-analysis
highlights abnormal EEG spectral characteristics during resting (in-
creased delta, theta, and high beta power; decreased alpha power,
Boutros et al., 2008). Reduced alpha frequency is also reported in both
chronic and ﬁrst psychotic episode patients (Harris et al., 2006;
Murphy and Ongur, 2019). Moreover, EEG features during NREM sleep
(slow-waves and sleep spindles) are reduced in patients. Several re-
search groups have reported sleep spindle deﬁcits in chronic
(Ferrarelli et al., 2007; Seeck-Hirschner et al., 2010; Wamsley et al.,
2012), ﬁst-episode and antipsychotic-naïve patients (Manoach et al.,
2014; Schilling et al., 2017). A recent meta-analysis (Chan et al., 2017)
indicates a lack of signiﬁcant alteration of both slow-waves and sleep
spindles. However, this might be due to methodological differences re-
garding sleep spindle quantiﬁcation (manual versus automatic), and to
the fact that slow-waves are not affected in stable chronic patients. By
contrast, slow-waves are reduced during the acute and/or early phases
of the disease and correlate with the symptom severity (Kaskie et al.,
2019). Taken together, sleep and awake resting EEG reveal diverse ab-
normalities in brain activity that may relate to alterations within the
thalamus and thalamo-cortical circuits.
To conclude, MRI and EEG studies provide compelling evidence for a
diversity of anomalies related to the thalamus in both ﬁrst psychotic ep-
isode and chronic schizophrenia patients (Table 2). These include re-
duced volume of the whole thalamus, reduced GM (mostly in anterior,
mediodorsal, posterior regions), decreased levels of NAA (a metabolite
involved in energymetabolism and potential marker of neuronal integ-
rity), abnormal connectivity with cortex, basal ganglia, cerebellum, and
hippocampus. Overall, these alterations are similar in the early and later
stages of schizophrenia and donot evolve drasticallywith the chronicity
of the disease. Of note, medicated patients appear to display less pro-
nounced reduction of the thalamus volume than antipsychotic-naive
patients, suggesting a partial normalization effect by pharmacological
treatments. The next chapter will review the existing literature in ge-
netic and clinical high-risk subjects.
3. Thalamus-related abnormalities in genetic and clinical high-risk
individuals
Here, we consider as clinical high-risk individuals (CHR) those who
meet the clinical criteria for high risk to psychosis (Fusar-Poli et al.,Please cite this article as: P. Steullet, Thalamus-related anomalies as cand
search, https://doi.org/10.1016/j.schres.2019.05.0272013). Genetic or familial high-risk subjects refer to unaffected rela-
tives/siblings who do not reach the criteria of clinical high-risk. This
does not however exclude that some genetic high-risk individuals (par-
ticularly the youngest ones) in the reported studies would not develop
schizophrenia or other psychiatric disorders later in life, well after the
completion of the studies.
3.1. MRI studies
3.1.1. Thalamic structural alterations
Structural thalamic anomalies are already present in CHR and ge-
netic high-risk subjects. Reduced thalamic volume has been observed
in both CHR (Harrisberger et al., 2016; Lunsford-Avery et al., 2013)
and subjects having affected relatives (Lawrie et al., 1999; Lawrie
et al., 2001). Lawrie's data suggests that reduced thalamic size may be
a genetically mediated risk factor. A meta-analysis of VBM studies also
supports a reduction of thalamic GM volume in familial high-risk sub-
jects (Cooper et al., 2014). One study shows that the thalamic GM vol-
ume in healthy siblings from patients suffering of schizophrenia is
intermediate between that of their probands and control subjects
(Staal et al., 1998). However, a meta-analysis of VBM studies did not re-
veal any signiﬁcant loss of GM in the thalamus of CHR subjects (Dietsche
et al., 2017; Fusar-Poli et al., 2011a). This suggests that GM loss within
the thalamus is at best modest and conﬁned in limited subregions
prior to the emergence of psychosis. Indeed, one studyhas founda slight
decreased GM volume in the anterior part of the thalamus in healthy
siblings, as compared to control subjects (Pergola et al., 2017). Likewise,
thalamic shape alteration due to an inward surface deformation of the
anterior and posterior thalamus has been observed in genetic high-
risk individuals and was intermediate between their schizophrenia sib-
lings and healthy controls (Harms et al., 2007).
3.1.2. Neurochemical proﬁle alterations
Reduced levels of NAA is found in the thalamus of CHR (Brugger
et al., 2011), but also of genetic high-risk subjects (Legind et al., 2019;
Tandon et al., 2013; Yoo et al., 2009). Lower glutamate level has been
observed in the thalamus of CHR as compared to healthy controls
(Fusar-Poli et al., 2011b) and associatedwith a poor functional outcome
(Allen et al., 2015). By contrast in genetic high-risk subjects, studies
show overall high levels of glutamate or glutamate + glutamine
(Legind et al., 2019; Tandon et al., 2013; Yoo et al., 2009). It is therefore
tempting to postulate that high glutamate levels in genetic high-risk
may constitute a factor of resilience since low glutamate content ap-
pears to predict worse functional outcome in CHR.
3.1.3. Abnormal connectivity
Abnormal structural thalamo-cortical connections are reported dur-
ing prodromal state but these appear more modest than during ﬁrst-
episode psychosis (Cho et al., 2016). CHR subjects also display aberrant
functional coupling between the thalamus and cortex, striatum and cer-
ebellum (Anticevic et al., 2015; Bernard et al., 2017; Cao et al., 2018;
Dandash et al., 2014). The pattern of reduced functional thalamic con-
nectivity with prefrontal cortex and cerebellum and hyper-
connectivity with sensorimotor cortical areas are more pronounced in
individuals who transit to psychosis (Anticevic et al., 2015). Bernard
et al. (2017) have also found disturbed connectivity within cerebello-
thalamo-cortical circuits that were associated with worsening of posi-
tive symptoms in CHR. Likewise, a recent study in CHRhighlights abnor-
mal functional coupling between several cerebral cortical regions,
thalamus, and cerebellum (Cao et al., 2018). This aberrant connectivity
was more pronounced in individuals who converted to psychosis. The
authors have also observed a close to signiﬁcant association between
the functional connectivity and thalamic GM volume. This suggests a
possible link between altered thalamus integrity and aberrant func-
tional connectivity within circuits embedding the thalamus. Taken to-
gether, there is increasing evidence that abnormal connectivity withinidate mechanism-based biomarkers for psychosis, Schizophrenia Re-
Table 2
Summary of currently described thalamus-related anomalies in genetic high-risk and clinical high-risk individuals,ﬁrst-episode and early psychosis patients, and in subjects suffering from
chronic schizophrenia. The table also shows anomalies that have been reported to be signiﬁcantly stronger in prodromal subjects who converted into psychosis as compared with those
who did not convert.
Genetic high-risk Clinical high-risk Converters versus
non-converters
Early psychosis Chronic schizophrenia
Total volume Reduced (6) Reduced (4,5) N/A Reduced (3) Reduced (less than in
antipsychotic naive and early
psychotic patients) (1,2,3)
Gray matter (GM)
Whole thalamus Reduced (less than in
patients) (7,8)
No signiﬁcant reduction (9) N/A Inconsistency across studies.
Probably progressive
reduction (10)
Reduced (11)
Subregions Reduced in anterior regions
(12)
N/A N/A Reduced in anterior,
mediodorsal and posterior
regions (13,14)
Reduced in anterior,
mediodorsal and posterior
regions (12)
Shape deformation Deformation in anterior and
posterior regions (less than
in patients) (16)
N/A N/A Deformation in anterior,
medial, ventrolateral and
posterior regions (14,15)
Deformation in anterior,
medial, ventrolateral and
posterior regions (16)
Diffusion-weighted
imaging
(microstructure)
Whole thalamus N/A N/A N/A N/A Alterations (17,19)
Subregions N/A N/A N/A Alterations in mediodorsal
and posterior regions (20)
Alterations in anterior and
mediodorsal regions (18)
Neurochemicals Low NAA (22,24) Low NAA (22) N/A Low NAA (22) Low NAA (21)
High glutamate or glutamate
+ glutamine (23,24)
Low glutamate (25) Low glutamate
associated with poor
outcome (26)
Inconsistent alterations in
glutamate (27)
Inconsistent alterations in
glutamate (27)
Connectivity
Structural Reduced thalamus-PFC (31) Reduced thalamus-PFC
Increased thalamus-parietal
Ctx (less than in ﬁrst episode
patients) (30)
N/A Reduced thalamus-PFC
Increased thalamus-parietal
Ctx (30)
Reduced thalamus-PFC
Increased
thalamus-sensorimotor Ctx
Increased thalamus-occipital
Ctx (28,29)
Functional
(resting)
Modest reduced
thalamus-PFC during
attentional task (40)
Reduced thalamus-PFC
Reduced
thalamus-cerebellum
Increased
thalamus-sensorimotor Ctx
Reduced thalamus-basal
ganglia (37,38,39)
Reduced thalamus-PFC
Reduced
thalamus-cerebellum
Increased
thalamus-sensorimotor
Ctx
Reduced
thalamus-basal ganglia
(37,38)
Reduced thalamus-PFC
Reduced
thalamus-cerebellum
Increased
thalamus-sensorimotor Ctx
Reduced thalamus-basal
ganglia (35,36)
Reduced thalamus-PFC
Reduced thalamus-cerebellum
Increased
thalamus-sensorimotor Ctx
Reduced thalamus-basal
ganglia
Increased
thalamus-parahippocampus
(32,33,34)
EEG
Awake (resting) Decreased alpha peak
frequency (45)
Decreased alpha peak
frequency in posterior areas
Increased delta and theta
power in frontal areas (44)
Decreased alpha peak
frequency in posterior
areas
Increased delta and
theta power in frontal
areas (44)
Decreased alpha peak
frequency (42,43)
Decreased alpha peak
frequency and power
Increased delta power
Increased theta power
Increased beta power (41,42)
Microstates Altered (48) Altered (47) N/A Altered (46) Altered (46)
Sleep (NREM) Reduced spindles (less than
patients) (52,53)
N/A N/A Reduced spindles (52,53) Reduced spindles (49,50,51)
Reduced slow-waves (56) N/A N/A Reduced slow-waves (55) Not affected slow-waves (54)
N/A indicates readouts for which there is a lack of published data or may have been missed during the literature search.
References: 1) Haijma et al. (2013), 2) van Erp et al. (2016), 3) Adriano et al. (2010), 4) Harrisberger et al. (2016), 5) Lunsford-Avery et al. (2013), 6) Lawrie et al. (2001), 7) Cooper et al.
(2014), 8) Staal et al. (1998), 9) Fusar-Poli et al. (2011a), 10) Andreasen et al. (2011), 11) Glahn et al. (2008), 12) Pergola et al. (2015), 13), Janssen et al. (2012), 14) Qiu et al. (2009), 15)
Coscia et al. (2009), 16)Harms et al. (2007), 17) Li et al. (2016), 18) Rose et al. (2006), 19) Agarwal et al. (2008), 20) Cho et al. (2019b), 21) Kraguljac et al. (2012), 22) Brugger et al. (2011),
23) Legind et al. (2019), 24) Tandon et al. (2013), 25) Fusar-Poli et al. (2011b), 26) Allen et al. (2015), 27) Merritt et al. (2016), 28) Giraldo-Chica et al. (2018), 29) Marenco et al. (2012),
30) Cho et al. (2016), 31) Cho et al. (2019b), 32) Anticevic et al. (2014), 33) Avram et al. (2018), 34) Tu et al. (2013), 35) Martino et al. (2018), 36) Woodward and Heckers (2016), 37)
Anticevic et al. (2015), 38) Cao et al. (2018), 39) Bernard et al. (2017), 40) Antonucci et al. (2016), 41) Boutros et al. (2008), 42) Harris et al. (2006), 43)Murphy andOngur (2019), 44) van
Tricht et al. (2014), 45) Clementz et al. (1994), 46) Rieger et al. (2016), 47) Andreou et al. (2014), 48) Tomescu et al. (2015), 49) Ferrarelli et al. (2007), 50) Seeck-Hirschner et al. (2010),
51) Wamsley et al. (2012); 52) Manoach et al. (2014), 53) Schilling et al. (2017), 54) Chan et al. (2017), 55) Kaskie et al. (2019), 56) D'Agostino et al. (2018). Additional references are
provided in the text.
5P. Steullet / Schizophrenia Research xxx (xxxx) xxxseveral brain circuits, in which the thalamus represents one of the
nodes, is progressing during prodromal stage with the worsening of
the functional outcome and emergence of psychosis. Currently, resting
fMRI data in cohorts of genetic high-risk individuals are missing. How-
ever, there is report of reduced structural connectivity between thala-
mus and orbitofrontal cortex in unaffected relatives of schizophrenia
patients (Cho et al., 2019a).Moreover during an attentional task, amod-
est alteration of the functional coupling between prefrontal cortex and
thalamic regions encompassing the mediodorsal and intralaminar nu-
clei exists already in healthy siblings of patients (Antonucci et al.,Please cite this article as: P. Steullet, Thalamus-related anomalies as cand
search, https://doi.org/10.1016/j.schres.2019.05.0272016). This suggests that a weakened connectivity between thalamus
and prefrontal regions may represent a heritable trait and vulnerability
factor.
3.2. EEG studies
The EEG microstate dynamic during resting is altered not only in
ﬁrst-episode and chronic patients (Rieger et al., 2016), but also in CHR
(Andreou et al., 2014). Likewise, adolescents with the 22q11 deletion
syndrome, who do not meet the diagnostic criteria for schizophreniaidate mechanism-based biomarkers for psychosis, Schizophrenia Re-
6 P. Steullet / Schizophrenia Research xxx (xxxx) xxxbut present some positive symptoms, display similar abnormal micro-
state dynamic as schizophrenia patients (Tomescu et al., 2015). van
Tricht et al. (2014) found increased frontal delta and theta oscillations
during rest in CHR subjects who convert to psychosis but not in non-
converters. This was accompanied by a decreased alpha peak frequency
in posterior cortical areas in converters. In another study however, no
difference in EEG parameters has been detected between converters
and non-converters (Lavoie et al., 2012). In relatives of schizophrenia
patients, there is report of decreased alpha peak frequency (Clementz
et al., 1994). Current data also suggest EEG abnormalities during
NREM sleep in genetic high-risk subjects, while such data during pro-
dromal stage are still missing. Although less prominent than in schizo-
phrenia patients (Schilling et al., 2017), sleep spindle deﬁcits exist in
ﬁrst-degree relatives of schizophrenia patients (D'Agostino et al.,
2018; Manoach et al., 2014; Schilling et al., 2017) and are correlated
with magical ideation and with thalamic glutamine + glutamate levels
(Lustenberger et al., 2015). Likewise, decreased slow-waves are re-
ported in ﬁrst-degree relatives of individuals with schizophrenia
(D'Agostino et al., 2018).
4. Thalamus-related anomalies as biomarkers
4.1. Potent endophenotypes
The reviewed literature reveals that several thalamus-related anom-
alies are present in unaffected relatives/siblings who do not meet the
criteria for clinical high-risk (Table 2) and are potent endophenotypes.
These include 1) reduced thalamus volume (Lawrie et al., 2001), 2) re-
duced GM particularly in the anterior region (Cooper et al., 2014;
Harms et al., 2007; Pergola et al., 2017), 3) decreased NAA content
(Legind et al., 2019; Tandon et al., 2013), 4) reduced structural and func-
tional connectivity between thalamus and prefrontal cortex (Antonucci
et al., 2016; Cho et al., 2019a), 5) decreased alpha peak frequencyduring
resting EEG (Clementz et al., 1994), 6) reduced spindles and slow-
waves during NREM sleep (D'Agostino et al., 2018; Manoach et al.,
2014; Schilling et al., 2017). These strongly support that the integrity
and function of several thalamic nuclei (i.e. anterior complex and
TRN) and brain networks in which these nuclei are embedded (i.e.
thalamo-prefrontal circuits) are affected by a vulnerable genetic back-
ground. Thus, sleep spindle deﬁcits and possibly altered dynamic of
EEG microstates could be the result of aberrant function of the TRN.
Slow-waves decrease could be also associated with anomalies within
TRN-thalamocortical networks (Crunelli et al., 2015) including the
intralaminar and anterodorsal nuclei which contribute to these brain-
wide synchrony (Gent et al., 2018). Some of these thalamus-related
anomaliesmight be causal to cognitive deﬁcits in children of individuals
suffering from schizophrenia,most affected domains beingmemory and
processing speed (Hemager et al., 2018). Thus, sleep spindle activity
correlates with many cognitive domains and are particularly linked to
consolidation of procedural and declarative memories during sleep
(Clemens et al., 2005; Fogel and Smith, 2011; Manoach et al., 2014;
Nishida and Walker, 2007; van der Helm et al., 2011). Of note, alpha
peak frequency during resting EEG have been associated with cognitive
and memory performance (i.e. working memory, speed processing)
(Klimesch, 1999; Richard Clark et al., 2004). The genetic liability for
thalamus anomalies in relation to psychosis is supported by preclinical
studies. Several genes (i.e. GRM3, ERBB4, CACNA1I, DISC1) linked to
schizophrenia (Andrade et al., 2016; Ma et al., 2018; Mei and Nave,
2014; Ripke et al., 2014; Saini et al., 2017) are highly expressed in the
TRN and thalamus, encode proteins which inﬂuence thalamo-cortical
circuits (Ahrens et al., 2015; Astori et al., 2011; Dawson et al., 2015;
Gu et al., 2008; Richard et al., 2017; Turner and Salt, 2003; Wang et al.,
2015). Genetic deletion of NMDA receptors in midline thalamic nuclei
also produces schizophrenia-like phenotypes in mice (Yasuda et al.,
2017). Noteworthy, in mice susceptible to oxidative stress, alterations
of parvalbumin-expressing neurons in the TRN are present alreadyPlease cite this article as: P. Steullet, Thalamus-related anomalies as cand
search, https://doi.org/10.1016/j.schres.2019.05.027during early postnatal development and precede impairments of
parvalbumin interneurons in other subcortical (e.g. amygdala, globus
pallidus, hippocampus) and cortical regions (e.g. anterior cingulate cor-
tex) (Cabungcal et al., 2019). Early perturbation in thalamus integrity
and function could therefore impact the developmental trajectories of
other brain regions. Abnormal thalamic inputs into the cortex can affect
normal maturation and reﬁnement of cortical circuits (Anton-Bolanos
et al., 2018). Proper development and maturation of the reciprocal con-
nections between the thalamus and cortex require ﬁnely tuned inter-
play between the two regions (Anton-Bolanos et al., 2018; Lopez-
Bendito, 2018). Defaults in the thalamus could potentially lead to alter-
ations in thematuration of cortico-thalamic circuits. Data from EEG and
fMRI suggest disruption of normal development of thalamo-cortical
connectivity during adolescence in individual suffering from schizo-
phrenia. Thus during rest, delta, theta, beta and alpha oscillations in pa-
tients resembles those observed in adolescent healthy individuals
(Uhlhaas and Singer, 2011). Likewise, weak functional coupling be-
tween thalamus and prefrontal cortex in schizophrenia could result
from a failure of increased coupling between prefrontal cortex and
dorso-anterior parts of the thalamus (Fair et al., 2010). It is also tempt-
ing to propose that genetic-based thalamic alterationsmay rendermul-
tiple brain circuits susceptible to environmental stresses leading to the
emergence of psychosis and schizophrenia.
4.2. Candidate predictive biomarkers for functional outcome and psychosis
Current data strongly support that several thalamus-related anoma-
lies appear or worsen as the disorder progresses into psychosis and
schizophrenia (Table 2), suggesting they may be stage-speciﬁc bio-
markers. Some are directly linked to the thalamus integrity. These in-
clude 1) progressive decrease in GM (assessed in the whole thalamus)
from familial high-risk subjects to psychotic patients (Staal et al.,
1998), 2) progressive GM reduction in the mediodorsal and posterior
parts of the thalamus with the emergence of psychosis (Pergola et al.,
2017), 3) low level of glutamate during the prodromal stage (Allen
et al., 2015; Fusar-Poli et al., 2011b). Other potential biomarkers are
more circuit-based anomalies. They include 1) progressive aberrant
functional coupling between thalamus and several brain regions such
prefrontal and sensory-motor cortices, basal ganglia, and cerebellum
(Anticevic et al., 2015; Bernard et al., 2017; Cao et al., 2018), 2) progres-
sive increase in delta and theta power and decrease in alpha peak fre-
quency in resting EEG (van Tricht et al., 2014). Several of these
anomalies deserve attention as potential predictive biomarkers for
functional outcome and transition to psychosis. However, most pub-
lished studies are cross-sectional and do not informabout the predictive
value of the reported alterations in terms of future outcome. To date, the
most promising candidates as predictive biomarkers for the conversion
to psychosis are the abnormal functional coupling between thalamus,
prefrontal cortex, sensorimotor areas, basal ganglia and cerebellum.
Several prospective studies have shown that such aberrant functional
connectivity is associated with worsening of positive symptoms and is
more pronounced in individuals who convert to psychosis within the
following 1–2 years (Anticevic et al., 2015; Bernard et al., 2017; Cao
et al., 2018). These support that the transition into psychosis involves
an imbalance between several large-scale networks encompassing the
thalamus. Likewise, glutamate within the thalamus represents another
candidate biomarker, as low glutamate level has been associated with
poor functional outcome (Allen et al., 2015). The predicting value of
resting EEG has also been examined. One study reports that increased
frontal delta and theta power and decreased occipito-parietal alpha
peak frequency contribute to short-term prediction of a ﬁrst psychotic
episode (van Tricht et al., 2014). By contrast, Zimmermann et al.
(2010) found that the power in delta, theta, beta1, and beta2 bands in
frontal-central electrodes carry a predictive value for transition only
when combined with clinical scores. In both cases, the authors suggest
that EEG parameters could also be helpful to stratify prodromal subjectsidate mechanism-based biomarkers for psychosis, Schizophrenia Re-
7P. Steullet / Schizophrenia Research xxx (xxxx) xxxinto biologically or clinically relevant subgroups. Meanwhile, machine-
learning algorithms could predict psychosis from speciﬁc pattern of
beta and gamma oscillations (Ramyead et al., 2016). Another study
has however failed to predict psychosis in CHR when using the power
of frontal delta and alpha and occipital-parietal beta1 oscillations
(Clark et al., 2016). The lack of consistency across studies may lie in
part on differences in the EEG readouts selected for the prediction as-
sessment. Nevertheless, longitudinal prospective investigations on rest-
ing EEG during prodromal stage is of high interest and may eventually
lead to the identiﬁcation of validated EEG parameters as predictive bio-
markers. Thus, resting EEG and functional fMRI coupling between thal-
amus and cortical and subcortical regions may become useful readouts
to reﬁne the assessment of risk to develop schizophrenia in clinical
high-risk populations.
Current literature supports that the thalamus constitutes a node
withinmultiple large-scale brain circuits that are altered early on during
the course of the disorder. But due to the limitations of imaging tech-
niques in terms of resolution, contrast and analytical methods, most
studies have considered the thalamus as a whole despite the fact that
each individual nucleus belongs to distinct networks. Overall, the ante-
rior, mediodorsal, and posterior regions appear most affected. Progress
in imaging techniques and analytical approaches open new avenues to
investigate thalamic subregions associated with speciﬁc circuits
(Akram et al., 2018; Najdenovska et al., 2018). Themediodorsal nucleus
and pulvinar, both of which are affected in early psychosis and chronic
patients, are nowmore accessible to longitudinal prospective investiga-
tions of gray matter density, diffusion parameters (extracted from
diffusion-weighted MRI data). Characterization of the dynamic alter-
ations within mediodorsal and pulvinar and their respective connected
regions (see for connectivity: Ouhaz et al., 2018; Pessoa and Adolphs,
2010) during the prodromal and ﬁrst psychotic episode stages will be
helpful to determine the contribution of these regions and their associ-
ated circuits to the emergence of psychosis, worsening of cognitive
functions, and overall functional outcome. In this respect, parallel as-
sessment of cognitive domains known to depend on circuits
encompassing these nuclei (i.e. workingmemory and cognitive ﬂexibil-
ity for the mediodorsal nucleus, spatial visual attentional tasks for the
pulvinar) is of particular interest. A better understanding of the tempo-
ral changes occurring at thalamic nucleus level will be helpful for scru-
tinizing, via translational studies, the biological mechanisms involved in
the progression of the deﬁcits and symptoms associated with
schizophrenia.
5. Conclusion
Thalamus abnormalities appear a central core of schizophrenia pa-
thology. The review presents solid evidence for multiple thalamus-
related anomalies throughout the different stages of schizophrenia, in-
cluding in genetic and clinical high-risk subjects. This review also high-
lights the need to perform further speciﬁc investigations on several
readouts that are still missing in either clinical or genetic high-risk indi-
viduals (see Table 2). Several alterations are potent endophenotypes
and may constitute vulnerability factors for psychotic disorders (i.e. re-
duced thalamic volume, lowNAA level, decreased alpha peak frequency
in resting EEG, reduced spindles and slow-waves during NREM sleep).
Other anomalies carry a predictive value for transition to psychosis as
they are present during the prodromal stage and more prominent in
CHR with poor outcome (i.e. low glutamate level, altered connectivity
within cortico-striato-thalamic loops). The primary dysfunctions could
originate within the thalamus itself but may also stem from alterations
in other brain structures belonging to brain networks encompassing the
thalamus. The thalamus constitutes an entry point to investigate the
emergence and progression of circuit-based anomalies associated with
speciﬁc cognitive domains and/or symptoms. In this respect,
mediodorsal nucleus and pulvinar are particularly affected. Longitudinal
prospective assessment of the integrity and function of these two largePlease cite this article as: P. Steullet, Thalamus-related anomalies as cand
search, https://doi.org/10.1016/j.schres.2019.05.027nuclei and their associated circuits during the prodromal stage is there-
fore warranted. Together with the use of modern optogenetic and
chemogenetic approaches to probe the organization and function of
these circuits (Schmitt and Halassa, 2017) in relevant animal models,
this may unveil biological mechanisms that contribute to the emer-
gence of this psychiatric disorder.
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